Skip to main content
Livermore
Livermore
ZHEN

Profund Advisors LLC

SEC CIK
0001129919
Latest filing
Aug 11, 2026

NTLA holding history

Intellia Therapeutics, Inc. in every 13F filed by Profund Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

NTLA overviewAll 13F holders of NTLAFull Q2 2026 holdings

Shares (Q2 2026)
80,427
Value
$1.36M
% of portfolio
<0.1%
Quarters held
21
Since Q2 2021
Holdings of NTLA by Profund Advisors LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202680,427$1.36M<0.1%−8,628−9.7%ReducedHolders
Q1 202689,055$1.14M<0.1%+9,391+11.8%AddedHolders
Q4 202579,664$716.2K<0.1%+40,078+101.2%AddedHolders
Q3 202539,586$683.6K<0.1%+12,084+43.9%AddedHolders
Q2 202527,502$258.0K<0.1%−10,032−26.7%ReducedHolders
Q1 202537,534$266.9K<0.1%−11,589−23.6%ReducedHolders
Q4 202449,123$572.8K<0.1%−1,229−2.4%ReducedHolders
Q3 202450,352$1.03M<0.1%+11,405+29.3%AddedHolders
Q2 202438,947$871.6K<0.1%−9,353−19.4%ReducedHolders
Q1 202448,300$1.33M0.1%−2,676−5.2%ReducedHolders
Q4 202350,976$1.55M0.1%+10,515+26.0%AddedHolders
Q3 202340,461$1.28M0.1%+4,592+12.8%AddedHolders
Q2 202335,869$1.46M0.1%−269−0.7%ReducedHolders
Q1 202336,138$1.35M0.1%+24,603+213.3%AddedHolders
Q4 202211,535$402.5K<0.1%+1,458+14.5%AddedHolders
Q3 202210,077$564.0K<0.1%+412+4.3%AddedHolders
Q2 20229,665$500.0K<0.1%−1,021−9.6%ReducedHolders
Q1 202210,686$777.0K<0.1%−1,191−10.0%ReducedHolders
Q4 202111,877$1.40M<0.1%−1,221−9.3%ReducedHolders
Q3 202113,098$1.76M0.1%+11,222+598.2%AddedHolders
Q2 20211,876$303.0K<0.1%+1,876NewHolders